1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Incyte Corporation – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “Incyte Corporation - Product
Pipeline Review - 2012” provides data on the Incyte Corporation’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Incyte Corporation’s corporate website, SEC filings, investor
presentations and featured press releases, both from Incyte Corporation and
industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Incyte Corporation - Brief Incyte Corporation overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Incyte Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
Reasons to buy
- Evaluate Incyte Corporation’s strategic position with total access to detailed
information on its product pipeline.
- Assess the growth potential of Incyte Corporation in its therapy areas of focus.
2. - Identify new drug targets and therapeutic classes in the Incyte Corporation’s R&D
portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
Table of contents:
List of Tables 4
List of Figures 4
Incyte Corporation Snapshot 5
Incyte Corporation Overview 5
Key Information 5
Key Facts 5
Incyte Corporation – Research and Development Overview 6
Key Therapeutic Areas 6
Incyte Corporation – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Incyte Corporation – Pipeline Products Glance 12
Incyte Corporation – Late Stage Pipeline 12
Registration Filed Products/Combination Treatment Modalities 12
Phase III Products/Combination Treatment Modalities 13
Incyte Corporation Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Incyte Corporation – Drug Profiles 16
INCB024360 + Ipilimumab 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
INCB242360 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Jakafi 19
Product Description 19
Mechanism of Action
3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
IntelGenx Corp. – Product Pipeline Review – 2012
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012
JADO Technologies GmbH – Product Pipeline Review – 2012
Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012
NeuroSearch A/S – Product Pipeline Review – 2012
NovaDel Pharma, Inc. – Product Pipeline Review – 2012
Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012
4. Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com